Risk of HAART therapy in hepatitis C

被引:11
作者
McGovern, B [1 ]
Bica, I [1 ]
机构
[1] Tufts Univ New England Med Ctr, Div Infect Dis, Boston, MA 02111 USA
关键词
D O I
10.1053/jhep.2002.32094
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:730 / 730
页数:1
相关论文
共 11 条
[1]  
BALZARINI J, 1991, J BIOL CHEM, V266, P21509
[2]   Hyperlactatemia and antiretroviral therapy: The Swiss HIV Cohort Study [J].
Boubaker, K ;
Flepp, M ;
Sudre, P ;
Furrer, H ;
Haensel, A ;
Hirschel, B ;
Boggian, K ;
Chave, JP ;
Bernasconi, E ;
Egger, M ;
Opravil, M ;
Rickenbach, M ;
Francioli, P ;
Telenti, A .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (11) :1931-1937
[3]   Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy? [J].
Brinkman, K ;
Kakuda, TN .
CURRENT OPINION IN INFECTIOUS DISEASES, 2000, 13 (01) :5-11
[4]  
FROMENTY B, 1995, PHARMACOL THERAPEUT, V57, P101
[5]  
Johns DG, 1998, BIOCHEM PHARMACOL, V55, P1551, DOI 10.1016/S0006-2952(97)00664-3
[6]   Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: Results of a phase I/II trial [J].
Kovacs, JA ;
Bechtel, C ;
Davey, RT ;
Falloon, J ;
Polis, MA ;
Walker, RE ;
Metcalf, JA ;
Davey, V ;
Piscitelli, SC ;
Baseler, M ;
Dewar, R ;
Salzman, NP ;
Masur, H ;
Lane, HC .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) :840-848
[7]   Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection [J].
Lafeuillade, A ;
Hittinger, G ;
Chadapaud, S .
LANCET, 2001, 357 (9252) :280-281
[8]   Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs [J].
Moore, RD ;
Keruly, JC ;
Chaisson, RE .
AIDS, 2001, 15 (05) :617-620
[9]   Hydroxyurea to inhibit human immunodeficiency virus-1 replication [J].
Romanelli, F ;
Pomeroy, C ;
Smith, KM .
PHARMACOTHERAPY, 1999, 19 (02) :196-204
[10]  
Salmon-Céron D, 2001, LANCET, V357, P1803, DOI 10.1016/S0140-6736(00)04921-7